Alto Neuroscience (ANRO) Other Non Operating Income (2025)
Alto Neuroscience's (ANRO) quarterly Other Non Operating Income came in at -$681000.0 in Q1 2025.
Alto Neuroscience (ANRO) Other Non Operating Income (2025) Analysis & Trends
Alto Neuroscience has disclosed Other Non Operating Income across 1 years of filings, most recently posting -$681000.0 for Q1 2025.
- Other Non Operating Income for Q1 2025 came in at -$681000.0, changed N/A year-over-year; the trailing twelve-month figure through Dec 2025 was -$681000.0 (changed N/A YoY), and the FY2025 annual result was -$681000.0, changed N/A from the prior year.
- Other Non Operating Income came in at -$681000.0 for Q1 2025 at Alto Neuroscience.
- In the past five years, Other Non Operating Income ranged from a high of -$681000.0 in Q1 2025 to a low of -$681000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - |
| 10 | Alto Neuroscience | 643.06 Mn | 379.30 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | -681,000.00 |